Last reviewed · How we verify

Esbatal — Competitive Intelligence Brief

Esbatal (betanidine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: betanidine. Area: Neuroscience.

marketed betanidine Sodium-dependent noradrenaline transporter Neuroscience Live · refreshed every 30 min

Target snapshot

Esbatal (betanidine).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Esbatal TARGET betanidine marketed betanidine Sodium-dependent noradrenaline transporter
Strattera ATOMOXETINE Eli Lilly marketed Norepinephrine Reuptake Inhibitor Sodium-dependent noradrenaline transporter 2002-01-01
Propadrine PHENYLPROPANOLAMINE Alpharma Us Pharms marketed Indirectly Acting Sympathomimetic Amines Sodium-dependent noradrenaline transporter 2000-01-01
Edronax REBOXETINE marketed reboxetine Sodium-dependent noradrenaline transporter 1997-01-01
Rilutek RILUZOLE Covis marketed Benzothiazole [EPC] Sodium-dependent noradrenaline transporter 1995-01-01
Fenmetrazina PHENMETRAZINE Boehringer Ingelheim marketed phenmetrazine Sodium-dependent noradrenaline transporter 1982-01-01
Sanorex MAZINDOL marketed mazindol Sodium-dependent noradrenaline transporter 1973-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (betanidine class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Esbatal — Competitive Intelligence Brief. https://druglandscape.com/ci/betanidine. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: